Nuclear factor κB is a key transcription factor in the duodenal contractility alterations induced by lipopolysaccharide

Experimental Physiology

Volumn 96, Issue 11, 2011, Pages 1151-1162

  Hernández, Ligia Verónica ^a   Gonzalo, Sergio ^a   Castro, Marta ^a   Arruebo, María Pilar ^a   Plaza, Miguel Angel ^a   Murillo, María Divina ^a   Grasa, Laura ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CARBONYL DERIVATIVE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; SODIUM CHLORIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DUODENUM MOTILITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATIVE STRESS; PLASMA; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 80055055656     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.060830     Document Type: Article

References (44)

1. Axelsson LG & Ahlstedt S (1990). Immune complex induced experimental colitis: beneficial effect of sulphasalazine in rabbits. Aliment Pharmacol Ther 4, 255-263.
2. Bird HA (1995). Sulphasalazine, sulphapyridine or 5-aminosalicylic acid - which is the active moiety in rheumatoid arthritis? Br J Rheumatol 34(Suppl 2), 16-19.
3. Bondeson J, Browne KA, Brennan FM, Foxwell BM & Feldmann M (1999). Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J Immunol 162, 2939-2945.
4. Chuang YH, Chuang WL, Huang SP, Liu CK & Huang CH (2009). Inhibition of nuclear factor-κB (NF-κB) activation attenuates ureteric damage in obstructive uropathy. Pharmacol Res 60, 347-357.
5. Cohen J (2002). The immunopathogenesis of sepsis. Nature 420, 885-891.
6. Collins SM (1996). The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111, 1683-1699.
7. De Filippis D, Iuvone T, Esposito G, Steardo L, Arnold GH, Paul AP, De Man Joris G & De Winter Benedicte Y (2008). Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J Pineal Res 44, 45-51.
8. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG & Hsueh W (2000). Lipopolysaccharide activates nuclear factor κB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. Br J Pharmacol 129, 307-314.
9. Eskandari MK, Kalff JC, Billiar TR, Lee KK & Bauer AJ (1997). Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol Gastrointest Liver Physiol 273, G727-G734.
10. Eskandari MK, Kalff JC, Billiar TR, Lee KK & Bauer AJ (1999). LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol Gastrointest Liver Physiol 277, G478-G486.
11. Esterbauer H & Cheeseman KH (1990). Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186, 407-421.
12. Giralt M, Gasull T, Blánquez A & Hidalgo J (1993). Effect of endotoxin on rat serum, lung and liver lipid peroxidation and on tissue metallothionein levels. Rev Esp Fisiol 49, 73-78.
13. Gonzalo S, Grasa L, Arruebo MP, Plaza MA & Murillo MD (2010). Inhibition of p38 MAPK improves intestinal disturbances and oxidative stress induced in a rabbit endotoxemia model. Neurogastroenterol Motil 22, 564-572, e123.
14. 2 and vanadate-evoked contractions in rabbit duodenum in vitro. J Physiol Pharmacol 57, 279-289.
15. Grasa L, Arruebo MP, Plaza MA & Murillo MD (2008). A downregulation of nNOS is associated to dysmotility evoked by lipopolysaccharide in rabbit duodenum. J Physiol Pharmacol 59, 511-524.
16. Hoult JR & Moore PK (1980). Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle. Br J Pharmacol 68, 719-730.
17. Karima R, Matsumoto S, Higashi H & Matsushima K (1999). The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5, 123-132.
18. Kaul DK, Liu XD, Choong S, Belcher JD, Vercellotti GM & Hebbel RP (2004). Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol 287, H293-H301.
19. 2+ channels and its reversal by NF-κB inhibitors in Crohn's colitis model. Am J Physiol Gastrointest Liver Physiol 285, G483-G493.
20. Kovacich JC, Boyle EM Jr, Morgan EN, Canty TG Jr, Farr AL, Caps MT, Frank N, Pohlman TH & Verrier ED (1999). Inhibition of the transcriptional activator protein nuclear factor κB prevents hemodynamic instability associated with the whole-body inflammatory response syndrome. J Thorac Cardiovasc Surg 118, 154-162.
21. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S & Stadtman ER (1990). Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186, 464-478.
22. Liu SF, Ye X & Malik AB (1999). Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 55, 658-667.
23. Liu YW, Chen CC, Tseng HP & Chang WC (2006). Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-κB-induced CCAAT/enhancer-binding protein δ in mouse macrophages. Cell Signal 18, 1492-1500.
24. Lodato RF, Khan AR, Zembowicz MJ, Weisbrodt NW, Pressley TA, Li YF, Lodato JA, Zembowicz A & Moody FG (1999). Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. Am J Physiol Gastrointest Liver Physiol 276, G1356-G1362.
25. Muerkoster S, Arlt A, Witt M, Gehrz A, Haye S, March C, Grohmann F, Wegehenkel K, Kalthoff H, Folsch UR & Schafer H (2003). Usage of the NF-κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer 104, 469-476.
26. Nowak D, Pietras T, Antczak A, Krol M & Piasecka G (1993). Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice. Antonie Van Leeuwenhoek 63, 77-83.
27. Opal SM (2007). The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 297, 365-377.
28. Oviedo J, Ochoa A, López J, Valdez J & Baizabal V (2005). Interferencia molecular en la ruta de transducción de NF-κB por bacterias patógenas. Revista de Educacion Bioquimica 24, 12-20.
29. Pahl HL (1999). Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866.
30. Palacios I, Lopez-Armada MJ, Hernandez P, Sanchez-Pernaute O, Gutierrez S, Miguelez R, Martinez J, Egido J & Herrero-Beaumont G (1998). Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells. Clin Exp Immunol 111, 588-596.
31. Ramirez K, Huerta R, Oswald E, Garcia-Tovar C, Hernandez JM & Navarro-Garcia F (2005). Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits. Infect Immun 73, 103-113.
32. Rebollar E, Arruebo MP, Plaza MA & Murillo MD (2002). Effect of lipopolysaccharide on rabbit small intestine muscle contractility in vitro: role of prostaglandins. Neurogastroenterol Motil 14, 633-642.
33. +-induced contractions in rabbit small intestine. Acta Physiol Scand 179, 299-307.
34. Riis P, Anthonisen P, Wulff HR, Folkenborg O, Bonnevie O & Binder V (1973). The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Scand J Gastroenterol 8, 71-74.
35. Rodrigues A, Queiroz DB, Honda L, Silva EJ, Hall SH & Avellar MC (2008). Activation of Toll-like receptor 4 (TLR4) by in vivo and in vitro exposure of rat epididymis to lipopolysaccharide from Escherichia coli. Biol Reprod 79, 1135-1147.
36. Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S, Akira S, Uematsu S, Bignami P, Ceriani V, Menard S & Balsari A (2006). Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol 208, 47-54.
37. Shao DZ, Lee JJ, Huang WT, Liao JF & Lin MT (2004). Inhibition of nuclear factor-κB prevents staphylococcal enterotoxin A-induced fever. Mol Cell Biochem 262, 177-185.
38. Shi XZ, Lindholm PF & Sarna SK (2003). NF-κB activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells. Gastroenterology 124, 1369-1380.
39. Siebenlist U, Franzoso G & Brown K (1994). Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10, 405-455.
40. Swinney DC, Xu YZ, Scarafia LE, Lee I, Mak AY, Gan QF, Ramesha CS, Mulkins MA, Dunn J, So OY, Biegel T, Dinh M, Volkel P, Barnett J, Dalrymple SA, Lee S & Huber M (2002). A small molecule ubiquitination inhibitor blocks NF-κB-dependent cytokine expression in cells and rats. J Biol Chem 277, 23573-23581.
41. Tai YH, Tsai RY, Wang YH, Cherng CH, Tao PL, Liu TM & Wong CS (2008). Amitriptyline induces nuclear transcription factor-κB-dependent glutamate transporter upregulation in chronic morphine-infused rats. Neuroscience 153, 823-831.
42. Tak PP & Firestein GS (2001). NF-κB: a key role in inflammatory diseases. J Clin Invest 107, 7-11.
43. Wang H, Qu X, De Plaen IG & Hsueh W (2001). Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. Br J Pharmacol 133, 713-721.
44. Weisbrodt NW, Pressley TA, Li YF, Zembowicz MJ, Higham SC, Zembowicz A, Lodato RF & Moody FG (1996). Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide. Am J Physiol Gastrointest Liver Physiol 271, G454-G460.